MONTCLAIR, NJ -- The Cancer Center at Hackensack Meridian Health Mountainside Medical Center has established an affiliate agreement with John Theurer Cancer Center at Hackensack University Medical Center, a partnership that will enhance care in North Jersey.

“This new relationship is all about helping us live our mission, which is to transform health care in New Jersey and beyond,” said Robert Garrett, CEO of Hackensack Meridian Health. “We are proud to offer patients the most cutting-edge care, which includes access to advanced clinical trials, close to home and in a convenient location.’’

Under this contract, John Theurer Cancer Center will augment Mountainside Medical Center’s full service, multidisciplinary program with oncology specialists. John Theurer Cancer Center will be managing both outpatient and inpatient oncology at Mountainside Medical Center and will ensure the same level of quality patients have come to expect at John Theurer Cancer Center.  With this agreement, patients will have access to all clinical trials conducted by John Theurer Cancer Center. 

Sign Up for Nutley Newsletter
Our newsletter delivers the local news that you can trust.

“Since becoming a member of the Hackensack Meridian Health Network, our goal has been to optimize that affiliation to make clinical enhancements and elevate our caliber of care for complex illnesses such as cancer,’’ said John Fromhold, FACHE, Chief Executive Officer of Hackensack Meridian Health Mountainside Medical Center. “This arrangement, together with a recent strategic investment in leading edge radiation oncology technology, is significant for the communities we are privileged to serve because it ensures that the most current, world-class cancer treatment is conveniently available close to home.”

The extensive scope of activities covered under this agreement includes weekly tumor board case reviews; medical education for physicians and nurses including grand rounds; the development of protocols, policies and procedures; strategic planning; and staff performance assessment and hiring.

John Theurer Cancer Center, the largest and most comprehensive cancer center in New Jersey, is based at Hackensack Meridian Health Hackensack University Medical Center in Hackensack, New Jersey, one of US News & World Report’s “High Performing Hospitals” for Cancer, 2018-19. John Theurer Cancer Center is a consortium member of the Georgetown Lombardi  Comprehensive Cancer Center, an NCI-designated Comprehensive Cancer Center.

“Our relationship with Mountainside Medical Center was born out of a shared commitment to achieving the best patient outcomes,’’ said Andre Goy, MD, MS, chair of John Theurer Cancer Center. “Partnerships of this kind are crucial to the advancement of cancer care and research. We’re excited to share the knowledge and expertise we have acquired as a member of trailblazing cancer care consortia with colleagues and patients in suburban Essex and Passaic Counties via this affiliation.”

Special projects to be undertaken during the initial three-year contract term will focus on the development of a pain assessment and care plan; reducing inpatient admissions; clinical trial screening processes; and, hospice and palliative care. John A. Conti, M.D., will continue to serve as the Medical Director and Chief of Oncology, Donna McNamara, M.D., and Stuart Goldberg, M.D. will provide leadership support for this John Theurer Cancer Center affiliation and Brett Lewis, M.D., will serve as Medical Director of Radiation Oncology.

Mountainside Medical Center’s Cancer Program offers a “whole person” care approach. The hospital is equipped with advanced technology and staffed by experienced, compassionate medical, surgical and radiation oncologists who specialize in the treatment of various forms of cancer.  Patients are afforded access to the most current, effective treatment options in a convenient suburban setting.

In addition to establishing a partnership with the state’s largest, most prestigious cancer center, Mountainside Medical Center recently acquired cutting edge Truebeam® technology that benefits patients who require radiation therapy with fewer, shorter treatment visits and less risk of side effects.

For additional information, please visit